129 related articles for article (PubMed ID: 38278711)
1. Reply to Marco Moschini, Francesco Montorsi, Andrea Salonia, Giorgio Gandaglia and Alberto Briganti's Letter to the Editor Re: Francesco Soria, Matteo Rosazza, Simone Livoti, et al. Repeat Transurethral Resection (TUR) + Bacillus Calmette-Guérin (BCG) Versus Upfront Induction BCG After TUR in High-risk Non-muscle-invasive Bladder Cancer: Feasibility Phase of a Randomized Controlled Study. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2023.10.019.
Soria F; Gontero P
Eur Urol Focus; 2024 Jan; ():. PubMed ID: 38278711
[No Abstract] [Full Text] [Related]
2. Re: Francesco Soria, Matteo Rosazza, Simone Livoti, et al. Repeat Transurethral Resection (TUR) + Bacillus Calmette-Guérin (BCG) Versus Upfront Induction BCG After TUR in High-risk Non-muscle-invasive Bladder Cancer: Feasibility Phase of a Randomized Controlled Study. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2023.10.019.
Montorsi F; Moschini M; Salonia A; Gandaglia G; Briganti A
Eur Urol Focus; 2024 Jan; ():. PubMed ID: 38272719
[No Abstract] [Full Text] [Related]
3. Reply to Francesco Montorsi, Giuseppe Rosiello, Giorgio Gandaglia, Andrea Salonia, and Alberto Briganti's Letter to the Editor re: David D'Andrea, Francesco Soria, Rodolfo Hurle, et al. En Bloc Versus Conventional Resection of Primary Bladder Tumor (eBLOC): A Prospective, Multicenter, Open-label, Phase 3 Randomized Controlled Trial. Eur Urol Oncol 2023;6:508-15.
D'Andrea D; Soria F; Hurle R; Enikeev D; Kotov S; Régnier S; Xylinas E; Lusuardi L; Heidenreich A; Cai C; Frego N; Taraktin M; Ryabov M; Gontero P; Compérat E; Shariat SF;
Eur Urol Oncol; 2024 Jun; 7(3):639-640. PubMed ID: 37978025
[No Abstract] [Full Text] [Related]
4. Reply to Marc A. Furrer and Patrick Y. Wuethrich's and Francesco Montorsi, Marco Moschini, Giorgio Gandaglia, and Alberto Briganti's Letters to the Editor re: Jakob Klemm, Michael Rink, Markus Von Deimling, et al. Time-to-complication Patterns After Radical Cystectomy: A Secondary Analysis of a 30-day Morbidity Assessment Using the European Association of Urology Quality Criteria for Standardized Reporting. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2023.06.005.
Klemm J; Koelker M; Shariat SF; Fisch M; Vetterlein MW
Eur Urol Focus; 2023 Oct; ():. PubMed ID: 37806850
[No Abstract] [Full Text] [Related]
5. Reply to Marco Moschini, Francesco Montorsi, Giuseppe Rosiello, Andrea Salonia, and Alberto Briganti's Letter to the Editor re: Stamatios Katsimperis, Lazaros Tzelves, Zafer Tandogdu, et al. Complications After Radical Cystectomy: A Systematic Review and Meta-analysis of Randomized Controlled Trials with a Meta-regression Analysis. Eur Urol Focus 2023;9:920-9.
Katsimperis S; Tzelves L; Tandogdu Z; Ta A; Geraghty R; Bellos T; Manolitsis I; Pyrgidis N; Schulz GB; Sridhar A; Shaw G; Kelly J; Skolarikos A
Eur Urol Focus; 2024 May; ():. PubMed ID: 38749880
[No Abstract] [Full Text] [Related]
6. Reply to Francesco Montorsi, Giorgio Gandaglia, Francesco Barletta, and Alberto Briganti's Letter to the Editor re: Piet Ost, Shankar Siva, Sugmund Brabrand, et al. PEACE V-Salvage Treatment of Oligorecurrent Nodal Prostate Cancer Metastases (STORM): Acute Toxicity of a Randomized Phase 2 Trial. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.09.007.
Zilli T; Ost P
Eur Urol Oncol; 2024 Feb; ():. PubMed ID: 38418267
[No Abstract] [Full Text] [Related]
7. Reply to Francesco Montorsi, Giorgio Gandaglia, Nicola Fossati, Andrea Salonia, and Alberto Briganti's Letter to the Editor re: Vasilis Stavrinides, Francesco Giganti, Bruce Trock, et al. Five-year Outcomes of Magnetic Resonance Imaging-based Active Surveillance for Prostate Cancer: A Large Cohort Study. Eur Urol 2020;78:443-51.
Stavrinides V; Giganti F; Emberton M; Moore CM
Eur Urol; 2020 Oct; 78(4):e166. PubMed ID: 32712048
[No Abstract] [Full Text] [Related]
8. Reply to Francesco Montorsi, Armando Stabile, Giorgio Gandaglia, and Alberto Briganti's Letter to the Editor re: K.R. Seetharam Bhat, Marcio Covas Moschovas, Marco Sandri, et al. Outcomes of Salvage Robot-assisted Radical Prostatectomy After Focal Ablation for Prostate Cancer in Comparison to Primary Robot-assisted Radical Prostatectomy: A Matched Analysis. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2021.10.005: Salvage Robotic Radical Prostatectomy for Recurrence After Focal Therapy-The Truth and Consequences.
Patel V; Bhat KRS; Moschovas MC; Noel J; Rogers T
Eur Urol Focus; 2022 Nov; 8(6):1864. PubMed ID: 35219650
[No Abstract] [Full Text] [Related]
9. Reply to Francesco Montorsi, Giorgio Gandaglia, Federico Dehò, Elio Mazzone, Armando Stabile, and Alberto Briganti's Letter to the Editor re: Dries Develtere, Giuseppe Rosiello, Pietro Piazza, et al. Early Catheter Removal on Postoperative Day 2 After Robot-assisted Radical Prostatectomy: Updated Real-life Experience with the Aalst Technique. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2021.10.003.
Develtere D; Bravi CA; Mottrie A
Eur Urol Focus; 2022 Nov; 8(6):1862-1863. PubMed ID: 35315318
[No Abstract] [Full Text] [Related]
10. Reply to Nicola Fossati, Giorgio Gandaglia, Alberto Bossi, Francesco Montorsi, Alberto Briganti's Letter to the Editor re: Stephen J. Freedland, Voleak Choeurng, Lauren Howard, et al. Utilization of a Genomic Classifier for Prediction of Metastasis Following Salvage Radiation Therapy After Radical Prostatectomy. Eur Urol 2016;70:588-96.
Freedland SJ; Den RB
Eur Urol; 2016 Oct; 70(4):e110-e111. PubMed ID: 26992279
[No Abstract] [Full Text] [Related]
11. Reply to Francesco Montorsi, Giorgio Gandaglia, and Alberto Briganti's Letter to the Editor re: Andrew J. Vickers. Effects of Magnetic Resonance Imaging Targeting on Overdiagnosis and Overtreatment of Prostate Cancer. Eur Urol 2021;80:567-72.
Vickers AJ
Eur Urol; 2021 Dec; 80(6):e149. PubMed ID: 34600778
[No Abstract] [Full Text] [Related]
12. Reply to Francesco Montorsi, Andrea Salonia, and Alberto Briganti's Letter to the Editor re: Lisa Moris, Marcus G. Cumberbatch, Thomas Van den Broeck, et al. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. Eur Urol 2020;77:614-27.
Moris L; Mottet N; Wiegel T;
Eur Urol; 2020 Nov; 78(5):e193-e194. PubMed ID: 32838999
[No Abstract] [Full Text] [Related]
13. Reply to Francesco Montorsi, Marco Bandini, and Andrea Necchi's Letter to the Editor re: Francesco Soria, Marco Moschini, David D'Andrea, et al. Comparative Effectiveness in Perioperative Outcomes of Robotic versus Open Radical Cystectomy: Results from a Multicenter Contemporary Retrospective Cohort Study. Eur Urol Focus 2020;6:1233-9.
Soria F; D'Andrea D; Gontero P; Shariat SF
Eur Urol Focus; 2022 Mar; 8(2):633-634. PubMed ID: 33875390
[No Abstract] [Full Text] [Related]
14. Reply to Francesco Montorsi, Armando Stabile, Elio Mazzone, Giorgio Gandaglia, and Alberto Briganti's Letter to the Editor re: Deepika Reddy, Max Peters, Taimur T. Shah, et al. Cancer Control Outcomes Following Focal Therapy Using High-intensity Focused Ultrasound in 1379 Men with Nonmetastatic Prostate Cancer: A Multi-institute 15-year Experience. Eur Urol 2022;81:407-13.
Reddy D; Ahmed HU
Eur Urol; 2022 Sep; 82(3):e74-e75. PubMed ID: 35690513
[No Abstract] [Full Text] [Related]
15. Reply to Francesco Montorsi, Nicola Fossati, Carlo A. Bravi, Giorgio Gandaglia, Nazareno Suardi, and Alberto Briganti's Letter to the Editor re: Sophie Knipper, Luigi Ascalone, Benjamin Ziegler, et al. Salvage Surgery in Patients with Local Recurrence After Radical Prostatectomy. Eur Urol 2021;79:537-44. Surgical Treatment of Local Recurrence Following Radical Prostatectomy: Reality or Illusion?
Knipper S; Maurer T
Eur Urol; 2021 May; 79(5):e134. PubMed ID: 33579574
[No Abstract] [Full Text] [Related]
16. Repeat Transurethral Resection (TUR) + Bacillus Calmette-Guérin (BCG) Versus Upfront Induction BCG After TUR in High-risk Non-muscle-invasive Bladder Cancer: Feasibility Phase of a Randomized Controlled Study.
Soria F; Rosazza M; Livoti S; Dutto D; Colucci F; Sylvester RJ; Shariat SF; Babjuk M; Palou J; Gontero P
Eur Urol Focus; 2023 Nov; ():. PubMed ID: 37923633
[TBL] [Abstract][Full Text] [Related]
17. Reply to Francesco Montorsi, Giorgio Gandaglia, Alberto Briganti's Letter to the Editor, re: Veeru Kasivisvanathan, Armando Stabile, Joana B. Neves, et al. Magnetic Resonance Imaging-targeted Biopsy Versus Systematic Biopsy in the Detection of Prostate Cancer: A Systematic Review, Meta-analysis. Eur Urol 2019;76:284-303: The choice of diagnostic test in prostate cancer is a balance of the risks and benefits: One size may not fit all.
Kasivisvanathan V; Takwoingi Y; Emberton M; Moore CM
Eur Urol; 2019 Nov; 76(5):e133-e134. PubMed ID: 31400949
[No Abstract] [Full Text] [Related]
18. Reply from Authors re: Giorgio Gandaglia, Alberto Briganti, Andrea Salonia, Francesco Montorsi. Excellent Erectile Function Recovery after Focal Therapy: Is This Enough? Eur Urol 2016;69:852-3: Focal Therapy Preserves Erectile Function in Men with Prostate Cancer.
Yap T; Ahmed HU; Hindley RG; Guillaumier S; McCartan N; Dickinson L; Emberton M; Minhas S
Eur Urol; 2016 May; 69(5):853-4. PubMed ID: 26695002
[No Abstract] [Full Text] [Related]
19. Reply to Giorgio Gandaglia, Alberto Briganti, Daniele Raggi, et al's Letter to the Editor re: Philipp Mandel, Benedikt Hoeh, Mike Wenzel, et al. Triplet or Doublet Therapy in Metastatic Hormone-sensitive Prostate Cancer Patients: A Systematic Review and Network Meta-analysis. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2022.08.007.
Hoeh B; Chun FKH; Mandel P
Eur Urol Focus; 2023 Feb; ():. PubMed ID: 36813619
[No Abstract] [Full Text] [Related]
20. Reply to Francesco Montorsi, Giuseppe Rosiello, and Giorgio Gandaglia's Letter to the Editor re: Roberto Contieri, Patrick J. Hensley, Wei Shen Tan, et al. Oncological Outcomes for Patients with European Association of Urology Very High-risk Non-muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin or Early Radical Cystectomy. Eur Urol Oncol. 2023;6:590-596.
Contieri R; Hensley PJ; Kamat AM
Eur Urol Oncol; 2024 Apr; 7(2):301. PubMed ID: 37806840
[No Abstract] [Full Text] [Related]
[Next] [New Search]
